Home › Breast Cancer › NCT05585788

Opioid Dispensing Device for Post-Operative Pain in Cancer Patients

Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and to Reduce Refills After Cancer-Related Surgery

Who can join

Ages 18 to 99 · All sexes

Inclusion Criteria:

* Adult patients (age greater than or equal to 18 years)
* Planned for major cancer-related surgery and expected to receive a postoperative opioid prescription
* Must speak English or Spanish
* Must have access to a smartphone or an alternative smart device (e.g., iPhone, Android phone, iPad, Surface, etc.).
* Co-enrollment in trials involving pharmacologic therapy is allowed

Exclusion Criteria:

* Patients who are taking opioids daily prior to the surgical procedure
* Patients unable to physically utilize the device
* Patients unable to self-administer medications
* Patients uncomfortable with using iPhone or iPad-based technology

About the study

This research study will evaluate the use of, and participants experience with, a new device called Addinex that safely stores and dispenses opioid medication. The purpose of this study is to evaluate the use of the Addinex device in cancer patients undergoing cancer-related surgery that require pain control with opioids after the surgery. Participants will be asked to answer questions about their medical history and background, fill out questionnaires, use a mobile application associated with the device, and undergo a phone interview one month after stopping use of the device. This study aims to find out how participants like using the Addinex device as opposed to a traditional pill bottle. Results of this study will help determine if the Addinex device could be useful to patients in the future after surgeries, as opposed to typical pill bottles.

What is being tested

• Addinex Device (ADX-27) (device)

Sponsor: Columbia University · Participants: 140 · Started: Oct 5, 2020

Contact the study team

• Research Nurse Navigator · Phone: 212-342-5162

Official record on ClinicalTrials.gov — NCT05585788

Locations in the U.S.

Conditions

• Breast Cancer

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.